Quantum BioPharma LtdQNTM
Price$3.42

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $257.1KTTM through 31 Dec 2025
Net Income -$23.6MTTM through 31 Dec 2025
Free Cash Flow -$8.2MTTM through 31 Dec 2025

Margins

Current
Gross Margin0.0%
Operating Margin-5,951.9%
Net Margin-9,182.0%

Balance Sheet Health

Debt / Equity0.26x
Current Ratio1.07x
Net Debt$580.2K
Cash & Equivalents$1.9M

Quality Metrics

FCF Margin-3,203.8%
Earnings-Beat Rate50.0%

Multi-Year Trend

Diluted EPS
'20'21'22
FY2022: $-0.61

Dividend

No dividend

Capital Allocation

Capex Intensity0.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.